In times of economic uncertainty, it's more important than ever to entrust your company's future to experienced management consultants who know your industry.

SCIENTIA ADVISORS is an international strategy consulting firm that helps senior executives in health care and life science companies select the right markets, choose attractive product opportunities, and streamline operations.

OUR CLIENTS range from Fortune 50 companies to emerging firms with cutting edge technologies in healthcare, biotechnology, devices, diagnostics, and therapeutics worldwide.

OUR TEAMS are composed entirely of experts with training and "real world" experience in both science and business.

OUR SPECIALTIES include strategies for corporate, product and customer growth, mergers, acquisitions, alliances, financing, and valuation.

OUR ENGAGEMENTS range in length from several weeks to a year. Because we focus solely on health care and the life sciences, we enter every engagement with deep understanding of pertinent technologies, products, markets, competitors, governments and regulators-- and the interrelationships among them.

OUR PROCESS is carried out in close collaboration with clients, features accurate, custom research, proprietary modeling, incisive analysis, interactive decision-making and sophisticated implementation planning.

OUR MISSION is to ensure that our clients outperform the market and the competition.

Scientia Advisors serves a global array of clients from our locations in Cambridge, Massachusetts and Palo Alto, California.

Scientia AdvisorsTM is a trademark of Scientia Advisors LLC.



Scientia in the News
HIT to Become a $60 B Market by 2013
Press Release
Health Information Technology Market will show "Impressive" Worldwide Growth, Scientia Advisors Finds
Latest Industry Briefing
The Underappreciated Cost-Saving Potential of Personalized Medicine in Health Reform Debate:
The current draft includes comparative effectiveness research but does not provide nearly as much funding as is needed for CER.
Latest Industry Review
Strategic Review of Healthcare Information Technology:
Opportunities and threats associated with accelerating HIT adoption